Bitcoin price today: falls to 2-week low below $113k ahead of Fed Jackson Hole
Investing.com - Biogen reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Biogen announced earnings per share of $5.25 on revenue of $2.59B. Analysts polled by Investing.com EPS of $4.13 on revenue of $2.49B.
Biogen 's are down 8% and is trading at $220.26 , still down 37.40% from its 52 week high of $351.86 set on Wednesday, August 18, 2021.
Biogen follows other major Healthcare sector earnings this month
Biogen's report follows an earnings beat by UnitedHealth on Friday, who reported EPS of $5.57 on revenue of $80.33B, EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on Tuesday with second quarter EPS of $2.59 on revenue of $24.02B, for EPS of $2.55 on revenue of $23.8B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar